
Reset all filters
01 15Incyte Corporation
Reset all filters
01 3TABLET
02 3TABLET;ORAL
03 9Tablet
Reset all filters
01 3Approved
02 3Authorized
03 3Limited-Term
04 3Prescription
05 3RX
Reset all filters
01 6PEMAZYRE
02 9Pemazyre
Reset all filters
01 3Canada
02 3Spain
03 3Sweden
04 3Switzerland
05 3USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PEMAZYRE
Dosage Form : TABLET;ORAL
Dosage Strength : 4.5MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PEMAZYRE
Dosage Form : TABLET;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PEMAZYRE
Dosage Form : TABLET;ORAL
Dosage Strength : 13.5MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 13.5mg
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000062
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 4.5mg
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000048
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000055
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Limited-Term
Registration Country : Switzerland
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 4.5mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 9mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 13.5mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PEMAZYRE
Dosage Form : TABLET
Dosage Strength : 4.5MG
Packaging :
Approval Date :
Application Number : 2519933
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PEMAZYRE
Dosage Form : TABLET
Dosage Strength : 9MG
Packaging :
Approval Date :
Application Number : 2519941
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PEMAZYRE
Dosage Form : TABLET
Dosage Strength : 13.5MG
Packaging :
Approval Date :
Application Number : 2519968
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 13.5MG
Packaging :
Approval Date : 2021-05-10
Application Number : 1211535005
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 4.5MG
Packaging :
Approval Date : 2021-05-07
Application Number : 1211535001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Pemazyre
Dosage Form : Tablet
Dosage Strength : 9MG
Packaging :
Approval Date : 2021-05-07
Application Number : 1211535003
Regulatory Info : Authorized
Registration Country : Spain